Norges Bank’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-375,713
Closed -$4.25M 2107
2022
Q2
$4.25M Buy
375,713
+106,383
+39% +$1.28M ﹤0.01% 1803
2022
Q1
$4.37M Buy
269,330
+186,133
+224% +$4.77M ﹤0.01% 1894
2021
Q4
$3.94M Sell
83,197
-160,697
-66% -$9.64M ﹤0.01% 1950
2021
Q3
$17.7M Buy
243,894
+213,894
+713% +$15.5M ﹤0.01% 1556
2021
Q2
$2.52M Hold
30,000
﹤0.01% 1991
2021
Q1
$1.45M Hold
30,000
﹤0.01% 2018
2020
Q4
$1.42M Hold
30,000
﹤0.01% 1991
2020
Q3
$1.41M Hold
30,000
﹤0.01% 1999
2020
Q2
$899K Hold
30,000
﹤0.01% 2017
2020
Q1
$390K Buy
+30,000
New +$375K ﹤0.01% 2018

Other funds holding NBP

Norges Bank's NBP Position: Q3 2022 in Review

Norges Bank sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 375,713 shares — an estimated $4.25M sold.

Norges Bank first reported a position in NBP in Q1 2020 and held it in 10 quarters. The position peaked at $17.7M in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Norges Bank reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Norges Bank sold 375,713 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $4.25M.
  • Norges Bank first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 10 quarters.
  • Norges Bank's NovaBridge Biosciences American Depositary Shares position peaked at $17.7M in Q3 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.